Cargando…
The Rac Inhibitor EHop-016 Inhibits Mammary Tumor Growth and Metastasis in a Nude Mouse Model
Metastatic disease still lacks effective treatments, and remains the primary cause of cancer mortality. Therefore, there is a critical need to develop better strategies to inhibit metastatic cancer. The Rho family GTPase Rac is an ideal target for anti-metastatic cancer therapy, because Rac is a key...
Autores principales: | Castillo-Pichardo, Linette, Humphries-Bickley, Tessa, De La Parra, Columba, Forestier-Roman, Ingrid, Martinez-Ferrer, Magaly, Hernandez, Eliud, Vlaar, Cornelis, Ferrer-Acosta, Yancy, Washington, Anthony V., Cubano, Luis A., Rodriguez-Orengo, Jose, Dharmawardhane, Suranganie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4225654/ https://www.ncbi.nlm.nih.gov/pubmed/25389450 http://dx.doi.org/10.1016/j.tranon.2014.07.004 |
Ejemplares similares
-
Rac and Cdc42 inhibitors reduce macrophage function in breast cancer preclinical models
por: Torres-Sanchez, Anamaris, et al.
Publicado: (2023) -
Dietary grape polyphenol resveratrol increases mammary tumor growth and metastasis in immunocompromised mice
por: Castillo-Pichardo, Linette, et al.
Publicado: (2013) -
Pharmacokinetics of the Rac/Cdc42 Inhibitor MBQ-167
in Mice by Supercritical Fluid Chromatography–Tandem Mass Spectrometry
por: Maldonado, María del Mar, et al.
Publicado: (2019) -
Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade
por: Rivera Rivera, Amilcar, et al.
Publicado: (2016) -
Characterization of Novel Derivatives of MBQ-167, an Inhibitor of the GTP-binding Proteins Rac/Cdc42
por: Medina, Julia I., et al.
Publicado: (2022)